(Q33908441)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

29 July 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Prostate cancer screening in the Tyrol, Austria: experience and results (English)

1 reference

prostate cancer screening

29 July 2017

0 references

1 reference

1 reference

Horninger W

1

1 reference

29 July 2017

Reissigl A

2

1 reference

29 July 2017

Rogatsch H

3

1 reference

29 July 2017

Volgger H

4

1 reference

29 July 2017

Studen M

5

1 reference

29 July 2017

Klocker H

6

1 reference

29 July 2017

Bartsch G

7

1 reference

29 July 2017

language of work or name

1 reference

1 June 2000

1 reference

European Journal of Cancer

29 July 2017

published in

1 reference

29 July 2017

volume

36

1 reference

29 July 2017

issue

10

1 reference

29 July 2017

page(s)

1322-1335

1 reference

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen ERA.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900113-1

7 January 2021

Serum prostate specific antigen as pre-screening test for prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/S0959-8049(00)00113-1

Identifiers

DOI

10.1016/S0959-8049(00)00113-1

1 reference

29 July 2017

1 reference